U.S. FDA seeks new warnings on drugs from Pfizer, Lilly and AbbVie – Reuters
Syringe and vial are seen in front of displayed the new Pfizer logo. REUTERS/Dado RuvicSept 1 (Reuters) – The U.S. drug regulator has asked Pfizer (PFE.N), Eli Lilly & Co (LLY.N) and AbbVie (ABBV.N) to include information about risks of serious conditions…
